Salix Pharmaceuticals Management Discusses Q3 2012 Results – Earnings Call …
Salix Pharmaceuticals Management Discusses Q3 2012 Results – Earnings Call …
Filed under: drug treatment news 2012
On July 27, 2012, the company received from the FDA a Complete Response Letter, or CRL, requesting additional clinical data for our supplemental New Drug Application for RELISTOR, which is methylnaltrexone bromide, injection for subcutaneous use for …
Read more on Seeking Alpha
Arena's CEO Discusses Q3 2012 Results – Earnings Call Transcript
Filed under: drug treatment news 2012
The most significant event in our history is about to occur, the availability of our first internally discovered drug BELVIQ. So, first, I'd like to review our long-term vision for Arena. I believe BELVIQ as a single agent will be an important …
Read more on Seeking Alpha
Amgen's Heart Drug Lowers Patient Cholesterol in Study
Filed under: drug treatment news 2012
Amgen's Heart Drug Lowers Patient Cholesterol in Study. By Ryan Flinn on November 06, 2012 … meeting in Los Angeles. Some of the patients were also taking Merck & Co.'s cholesterol treatment Zetia. Amgen's drug is one of several that companies are …
Read more on Businessweek
Light Therapy Company Gets FDA Warning Letter
Filed under: drug treatment news 2012
Nov 07, 2012. The U.S. Food and Drug Administration announced it issued a Warning Letter on Nov. … 15, 2012. "In its Sept. 21, 2012, response, The Avalon Effect said that the company did not intend for any of its products to be used in the treatment …
Read more on Occupational Health and Safety